WHRIN documents 19 actions led by women and gender expansive people who use drugs across 16 countries, with this year's campaign marked by country-level coordination and consortium collaborations that increased the reach of collective action.
Kankainen and Tammi draw on a recent regional conference to examine the growing importance of human rights, civic participation and democracy in Nordic drug policy debates.
HRI, IDPC and EHRA highlight the barriers faced by people who use drugs in accessing essential medicines and harm reduction services, calling on states to reform drug policies and invest in the harm reduction response.
The UN Expert Mechanism on Racial Justice and Equality in Law Enforcement calls for a fundamental shift away from punitive and militarised drug policies towards decriminalisation, responsible regulation and approaches grounded in racial justice, human rights, public health and community participation.
IDPC reflects on two decades of collective action and a year of resilience, highlighting advances in human rights, international drug policy reform and grassroots mobilisation, despite political backlash, shrinking civic space and funding cuts.
The Global Fund highlights these interventions' potential to expand treatment choice, reduce HIV and HCV transmission risks, and strengthen accessible, community-informed harm reduction services.
UNAIDS and partners call for sustained, locally owned action to tackle discrimination, expand harm reduction and strengthen the meaningful participation of people who use drugs.
WOLA documents how the US' lethal bombing campaign amounts to extrajudicial execution, has had little impact on cocaine trafficking, and demands an immediate end and accountability.
The Global Partnership on Drug Policies and Development reflects on ten years of the Brandenburg Forum and its contribution to more humane, development-oriented, evidence-based and rights-affirming drug policies.
Gilmour et al. find no statistically observable impact of Oregon’s drug decriminalisation policy on opioid overdose mortality, challenging claims that the reform caused the state’s rise in deaths.
IDPC discusses the Commission's post-consensus 'new normal' and how it creates opportunities for progress on harm reduction and reform amid growing divisions and threats to rights.
IDPC, CELS, HRI and WOLA warn that conflating drug trafficking with terrorism enables unlawful military action, weakens human rights protections and restricts civil society space.
